Economic analysis of a single institutional review board data exchange standard in multisite clinical studies

Eric L. Eisenstein, Anita Walden, Katrina Donovan, Meredith N. Zozus, Feliciano B. Yu, Vivian L. West, W. Ed Hammond, Lawrence H. Muhlbaier

Resultado de la investigación: Articlerevisión exhaustiva

Resumen

Background: Single Institutional Review Boards (sIRB) are not achieving the benefits envisioned by the National Institutes of Health. The recently published Health Level Seven (HL7®) Fast Healthcare Interoperability Resources (FHIR®) data exchange standard seeks to improve sIRB operational efficiency. Methods and results: We conducted a study to determine whether the use of this standard would be economically attractive for sIRB workflows collectively and for Reviewing and Relying institutions. We examined four sIRB-associated workflows at a single institution: (1) Initial Study Protocol Application, (2) Site Addition for an Approved sIRB study, (3) Continuing Review, and (4) Medical and Non-Medical Event Reporting. Task-level information identified personnel roles and their associated hour requirements for completion. Tasks that would be eliminated by the data exchange standard were identified. Personnel costs were estimated using annual salaries by role. No tasks would be eliminated in the Initial Study Protocol Application or Medical and Non-Medical Event Reporting workflows through use of the proposed data exchange standard. Site Addition workflow hours would be reduced by 2.50 h per site (from 15.50 to 13.00 h) and Continuing Review hours would be reduced by 9.00 h per site per study year (from 36.50 to 27.50 h). Associated costs savings were $251 for the Site Addition workflow (from $1609 to $1358) and $1033 for the Continuing Review workflow (from $4110 to $3076). Conclusion: Use of the proposed HL7 FHIR® data exchange standard would be economically attractive for sIRB workflows collectively and for each entity participating in the new workflows.

Idioma originalEnglish (US)
Número de artículo106953
PublicaciónContemporary Clinical Trials
Volumen122
DOI
EstadoPublished - nov. 2022

ASJC Scopus subject areas

  • Pharmacology (medical)

Huella

Profundice en los temas de investigación de 'Economic analysis of a single institutional review board data exchange standard in multisite clinical studies'. En conjunto forman una huella única.

Citar esto